Trials / Completed
CompletedNCT06898008
Characterization of Children with Complaints of Excessive Daytime Sleepiness
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
10% of the population suffers from excessive daytime sleepiness. This can be explained by a variety of etiologies: psychiatric disorders, altered sleep quantity or quality, hypersomnia... The consequences on quality of life are not negligible, with emotional, academic, social, financial and somatic repercussions. Diagnosing and managing them is essential. This is the role of the HFME's Child Sleep Service, a reference center for rare narcolepsy and hypersomnia, which carries out a weekly hypersomnia assessment. In this context, the investigators are carrying out a retrospective descriptive study, the primary objective of which is to describe the results and diagnoses of hypersomnia check-ups in the HFME's Sleep Department, in order to obtain feedback on the center's activity and its evolution. The secondary objectives are to characterize the patients in the different diagnostic groups, to highlight factors associated with the different diagnoses, and to describe changes in patient characteristics over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Assessment of socio-demographic, anthropometric, psychometric and clinical characteristics | age, sex and place of residence, socioeconomic level, education, anthropometric data, first-degree family history, screen time, physical activity time, sleep time, comorbidity, drug treatments, education, total IQ, results of Epworth, CDI, ISI, ADHD, CONNERS, SCSC, Horne and Ostberg questionnaires, hearing aids, referring professional, melatonin dosage, ferritinemia, etiology of sleepiness |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-01-05
- Completion
- 2024-10-31
- First posted
- 2025-03-27
- Last updated
- 2025-03-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06898008. Inclusion in this directory is not an endorsement.